By Dr. Chinta Sidharthan New research highlights how elevated levels of the iron-regulating hormone hepcidin contribute to ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

Psoriasis is a chronic, inflammatory, hyperproliferative skin disease with an etiology and pathogenesis that have undergone intense investigation during the past decade.

While the pathogenesis of psoriasis is complex and involves multiple steps, researchers highlight three key steps in the pathogenesis of psoriasis: T-cell activation by antigen in the lymph nodes ...

Sufficient data from a 12-week non-clinical toxicology study of VYN202 in dogs would be required in order to resume the trial in male clinical subjects, and the design of this toxicology study has ...

The researchers note that roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor, which targets inflammatory pathways central ...

Mice showing the first symptoms of a psoriasis-like phenotype were injected with anti-VEGF antibodies (n = 12) or an IgG isotype control (n = 8) every 48 hours for 8 days. By days 23–24, skin ...

AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn ...

Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these ...

The pathogenesis of psoriasis involves the IL-17/IL-23 axis, which plays a crucial role in disease development. PD-1 inhibitor-induced psoriasis is believed to result from prolonged neutrophil ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...